A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and Navocaftor

Clinical trial NCT05538585 · COMPLETED

Trial details

NCT number: NCT05538585
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2022-09-27
Primary completion: 2022-12-21
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.